Catheter Ablation for Atrial Fibrillation (for Idaho Only)
Customize your policy alerts
Sign up for UnitedHealthcare Policy CS197ID.D alerts
Get alerted when Policy CS197ID.D changes without checking for updates manually.
Monitor payer policy activity
State-specific UnitedHealthcare medical policy governing coverage of catheter ablation for atrial fibrillation for Idaho members, including Idaho Medicaid Plus plans.
Replaced reference to 'InterQual ® CP: Procedures, Electrophysiology (EP) Testing +/- Radiofrequency Ablation (RFA) or Cryothermal Ablation, Cardiac' with 'InterQual ® CP: Procedures, Electrophysiology (EP) Testing +/- Catheter Ablation, Cardiac'.
Catheter ablation for treating asymptomatic atrial fibrillation in individuals with a left ventricular ejection fraction greater than 40% is unproven and not medically necessary due to insufficient evidence of efficacy.
Added definition of 'Heart Failure With Reduced Ejection Fraction' (LVEF ≤ 40%).
Added Description of Services and Clinical Evidence sections and updated references.
Coverage Criteria for Catheter Ablation
Medical necessity and restrictions
Covered when supporting InterQual criteria are met; the policy distinguishes symptomatic or reduced LVEF patients from asymptomatic individuals with preserved LVEF.
Refer to InterQual criteria for specific inclusion/exclusion and clinical detail.
Supported by randomized trials and meta-analyses (e.g., CASTLE-AF) and cited guideline statements.
Requests in this population may be denied per policy.
This policy applies specifically to catheter ablation for atrial fibrillation and does not apply to members with arrhythmias other than atrial fibrillation. Medical necessity determinations for catheter ablation are based on the InterQual ® CP: Procedures, Electrophysiology (EP) Testing +/- Catheter Ablation, Cardiac criteria; refer to InterQual for the detailed inclusion, exclusion, and clinical requirements that support coverage.
Catheter ablation for treating asymptomatic atrial fibrillation in individuals with a left ventricular ejection fraction greater than 40% is considered unproven and not medically necessary due to insufficient evidence of efficacy.
Billing and Coding
| 93653 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia with right atrial pacing and recording and catheter ablation of arrhythmogenic focus, including intracardiac electrophysiologic 3- dimensional mapping, right ventricular pacing and recording, left atrial pacing and recording from coronary sinus or left atrium, and His bundle recording, when performed; with treatment of supraventricular tachycardia by ablation of fast or slow atrioventricular pathway, accessory atrioventricular connection, cavo-tricuspid isthmus or other single atrial focus or source of atrial re- entry. |
| 93655 | Intracardiac catheter ablation of a discrete mechanism of arrhythmia which is distinct from the primary ablated mechanism, including repeat diagnostic maneuvers, to treat a spontaneous or induced arrhythmia (List separately in addition to code for primary procedure). |
| 93656 | Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia including left or right atrial pacing/recording, and intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac electrophysiologic 3-dimensional mapping, intracardiac echocardiography with imaging supervision and interpretation, right ventricular pacing/recording, and His bundle recording, when performed. |
| 93657 | Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure). |
Provider Requirements and Prior Authorization
InterQual-based prior authorization required
Medical necessity determinations for catheter ablation reference InterQual® CP: Procedures, Electrophysiology (EP) Testing +/- Catheter Ablation, Cardiac; documentation consistent with InterQual criteria must be provided with authorization requests to support coverage.
Therapy sequencing: ablation appropriate after guideline‑directed therapy in symptomatic/HFrEF patients
Guidelines and randomized trials support catheter ablation for symptomatic patients and for individuals with heart failure with reduced ejection fraction (LVEF ≤ 40%) who are on guideline‑directed medical therapy; use of medical therapy prior to ablation is implied by guideline context and should be documented.
- Heart failure with reduced ejection fraction defined as LVEF ≤ 40%
Required medical record documentation for review
The patient’s medical record must contain documentation that fully supports medical necessity, including relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures; records must be legible and made available upon request.
Risk of denial if documentation is incomplete or unavailable
If the medical record does not contain the required history, exam, and diagnostic test results that support the InterQual-based criteria or coverage rationale, the request may be denied during review.
Asymptomatic AF with preserved LVEF (>40%) — not medically necessary
Requests for catheter ablation to treat asymptomatic atrial fibrillation in individuals with left ventricular ejection fraction greater than 40% are considered unproven and not medically necessary and may be denied.
- Threshold: LVEF > 40% constitutes not medically necessary/unproven use
Background and Clinical Evidence
Catheter ablation for atrial fibrillation is a percutaneous electrophysiology procedure that targets and eliminates arrhythmogenic atrial tissue using energy sources such as radiofrequency, cryothermal, or other catheter-delivered modalities. The procedure typically involves intracardiac mapping, placement of multiple electrode catheters (and transseptal access when left atrial work is required), pulmonary vein isolation to isolate triggers, and selective additional focal or linear ablation as indicated by procedural mapping.
Clinical guidelines and randomized trial data support catheter ablation for symptomatic patients and for selected individuals with heart failure and reduced left ventricular ejection fraction to improve outcomes. For Idaho members, coverage and medical necessity determinations follow the InterQual ® CP: Procedures, Electrophysiology (EP) Testing +/- Catheter Ablation, Cardiac criteria; documentation consistent with those criteria is required to demonstrate medical necessity.
Requests for ablation should be supported by the medical record, including history, examination, and pertinent diagnostic test results. Note that this policy was updated to reference the current InterQual criteria set and includes a specific coverage position that catheter ablation is not medically necessary for asymptomatic AF with LVEF > 40%.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.